BIOSYN VAGINAL MICROBICIDE PHASE I TRIALS PLANNED FOR SEPTEMBER
Executive Summary
BIOSYN VAGINAL MICROBICIDE PHASE I TRIALS PLANNED FOR SEPTEMBER, the Philadelphia-based company said July 7. The product, which has been tested in vitro for safety and efficacy in preventing the transmission of AIDS, will also be tested for contraceptive efficacy. The product was designed to combine both contraception and protection against multiple sexually transmitted diseases. The company said it will file an IND "shortly" for the new chemical entity, which it describes only as "a synthetic organic molecule."